Table 2 Tumor characteristics in the group living and deceased patients
Living | Deceased | p | |||||
|---|---|---|---|---|---|---|---|
Mean ± sd/n (%) | Median | Mean ± sd/n (%) | Median | ||||
Age | 70.3 ± 7.7 | 69.5 | 62.3 ± 8.7 | 63.0 | 0.087 | m | |
Sex | Female | 0 (0.0%) | 12 (6.9%) | 1.000 | X2 | ||
Male | 4 (100.0%) | 162 (93.1%) | |||||
Metastasis | |||||||
Brain | 0 (0.0%) | 24 (13.8%) | 1.000 | X2 | |||
Bone | 2 (50.0%) | 131 (75.3%) | 0.265 | X2 | |||
Liver | 0 (0.0%) | 84 (48.3%) | 0.123 | X2 | |||
Opp. lung | 0 (0.0%) | 11 (6.3%) | 1.000 | X2 | |||
Pleura | 1 (25.0%) | 24 (13.8%) | 0.457 | X2 | |||
Adrenal | 0 (0.0%) | 52 (29.9%) | 0.323 | X2 | |||
Pancreas | 0 (0.0%) | 16 (9.2%) | 1.000 | X2 | |||
Brain + bone | 0 (0.0%) | 5 (2.9%) | 1.000 | X2 | |||
Bone + liver | 0 (0.0%) | 31 (17.8%) | 1.000 | X2 | |||
Single metastasis | 4 (100.0%) | 53 (30.5%) | 0.010 | X2 | |||
Dual metastasis | 0 (0.0%) | 73 (42.0%) | 0.145 | X2 | |||
Three or more met. | 0 (0.0%) | 46 (26.4%) | 0.574 | X2 | |||
Tumor diameter (cm) | 0–3 | 1 (25.0%) | 17 (9.8%) | 0.349 | X2 | ||
3–7 | 2 (50.0%) | 88 (50.6%) | |||||
> 7 | 1 (25.0%) | 69 (39.7%) | |||||
Tumor N stage | I | 0 (0.0%) | 6 (3.4%) | 1.000 | X2 | ||
II | 1 (25.0%) | 59 (33.9%) | |||||
III | 3 (75.0%) | 109 (62.6%) | |||||